Fort LP Continues to Hold Position in Abbvie (ABBV); As Entegris (ENTG) Market Value Rose, Eagle Asset Management Cut Its Position

January 17, 2018 - By Louis Casey

Michael Novogratz increased its stake in Abbvie Inc (ABBV) by 5.95% based on its latest 2017Q3 regulatory filing with the SEC. Fort Lp bought 7,336 shares as the company’s stock rose 6.17% with the market. The hedge fund run by Michael Novogratz held 130,697 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $11.61 million, up from 123,361 at the end of the previous reported quarter. Fort Lp who had been investing in Abbvie Inc for a number of months, seems to be bullish on the $166.48B market cap company. The stock increased 1.75% or $1.791 during the last trading session, reaching $104.281. About 1.24 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since January 17, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

Eagle Asset Management Inc decreased its stake in Entegris Inc (ENTG) by 1.26% based on its latest 2017Q3 regulatory filing with the SEC. Eagle Asset Management Inc sold 29,362 shares as the company’s stock rose 6.38% with the market. The institutional investor held 2.30 million shares of the consumer non-durables company at the end of 2017Q3, valued at $67.14M, down from 2.32M at the end of the previous reported quarter. Eagle Asset Management Inc who had been investing in Entegris Inc for a number of months, seems to be less bullish one the $4.63 billion market cap company. The stock increased 1.32% or $0.42 during the last trading session, reaching $32.72. About 279,811 shares traded. Entegris, Inc. (NASDAQ:ENTG) has risen 78.11% since January 17, 2017 and is uptrending. It has outperformed by 61.41% the S&P500.

Since July 31, 2017, it had 0 buys, and 8 insider sales for $45.57 million activity. Michael Robert A. had sold 6,699 shares worth $589,512. SALEKI-GERHARDT AZITA sold $705,655 worth of stock or 8,300 shares. RICHMOND TIMOTHY J. sold $8.57 million worth of AbbVie Inc. (NYSE:ABBV) on Monday, December 18. Another trade for 87,899 shares valued at $6.24M was made by GONZALEZ RICHARD A on Thursday, August 3. Gosebruch Henry O also sold $1.66 million worth of AbbVie Inc. (NYSE:ABBV) on Monday, October 30.

Fort Lp, which manages about $349.60M and $406.56 million US Long portfolio, decreased its stake in Anthem Inc (NYSE:ANTM) by 69,586 shares to 90,780 shares, valued at $17.24M in 2017Q3, according to the filing. It also reduced its holding in Oracle Corp (NYSE:ORCL) by 75,850 shares in the quarter, leaving it with 167,927 shares, and cut its stake in Interpublic Group Cos Inc (NYSE:IPG).

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Abbvie Inc had 70 analyst reports since July 21, 2015 according to SRatingsIntel. BMO Capital Markets maintained the shares of ABBV in report on Sunday, July 30 with “Hold” rating. On Tuesday, December 5 the stock rating was maintained by Leerink Swann with “Buy”. Piper Jaffray maintained AbbVie Inc. (NYSE:ABBV) on Thursday, September 28 with “Buy” rating. The firm has “Hold” rating given on Wednesday, April 19 by BMO Capital Markets. The firm earned “Buy” rating on Friday, September 15 by Jefferies. The company was downgraded on Monday, June 6 by Cowen & Co. SunTrust initiated the stock with “Buy” rating in Wednesday, July 22 report. The rating was upgraded by Citigroup on Tuesday, February 23 to “Buy”. The rating was maintained by Cowen & Co with “Hold” on Friday, July 28. The firm earned “Buy” rating on Friday, October 23 by UBS.

Investors sentiment decreased to 0.85 in 2017 Q3. Its down 0.15, from 1 in 2017Q2. It is negative, as 55 investors sold ABBV shares while 640 reduced holdings. 132 funds opened positions while 462 raised stakes. 1.06 billion shares or 1.89% more from 1.04 billion shares in 2017Q2 were reported. Kentucky Retirement Insur Tru Fund holds 0.66% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 42,084 shares. Texas Yale Corp holds 29,583 shares or 0.23% of its portfolio. Summit Gru Limited Liability Com holds 0.11% or 7,000 shares. Franklin Street Advisors Incorporated Nc reported 184,285 shares. Loeb Partners accumulated 0.42% or 15,430 shares. Kanawha Capital Mngmt Ltd Llc, a Virginia-based fund reported 164,062 shares. First State Bank Of Hutchinson has invested 0.18% in AbbVie Inc. (NYSE:ABBV). 10 reported 25,437 shares stake. Utah Retirement holds 0.58% or 292,405 shares. Lodestar Counsel Ltd Liability Il holds 25,281 shares. Dupont Cap Mngmt invested in 0.18% or 90,748 shares. Supplemental Annuity Collective Of Nj holds 0.59% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 15,000 shares. 143,271 are owned by C Worldwide Grp Hldg A S. Clarivest Asset Management Ltd Limited Liability Company accumulated 354,565 shares. Boltwood Cap Management owns 10,902 shares for 0.63% of their portfolio.

Since August 14, 2017, it had 0 buys, and 5 insider sales for $799,122 activity. Another trade for 4,901 shares valued at $120,146 was sold by Burns Robert Nicholas. Shares for $393,750 were sold by Rucci Corey on Wednesday, September 6.

Eagle Asset Management Inc, which manages about $25.60B and $17.45B US Long portfolio, upped its stake in Chemical Financial Corp (NASDAQ:CHFC) by 12,542 shares to 598,738 shares, valued at $31.58 million in 2017Q3, according to the filing. It also increased its holding in Biohaven Pharmaceutical Hold by 434,809 shares in the quarter, for a total of 917,756 shares, and has risen its stake in Innospec Inc (NASDAQ:IOSP).

Investors sentiment decreased to 0.82 in Q3 2017. Its down 0.90, from 1.72 in 2017Q2. It dived, as 29 investors sold ENTG shares while 90 reduced holdings. 38 funds opened positions while 59 raised stakes. 135.35 million shares or 1.21% more from 133.74 million shares in 2017Q2 were reported. Hbk Invs LP holds 69,721 shares. Moreover, Tudor Et Al has 0.02% invested in Entegris, Inc. (NASDAQ:ENTG). Peoples Financial Svcs reported 0% stake. Morgan Stanley owns 218,420 shares or 0% of their US portfolio. Deutsche Retail Bank Ag invested in 826,051 shares or 0.02% of the stock. Barclays Public Ltd Liability Com owns 116,135 shares. Commonwealth Equity Services Incorporated holds 0% of its portfolio in Entegris, Inc. (NASDAQ:ENTG) for 17,537 shares. Thompson Davis Co has invested 0.14% in Entegris, Inc. (NASDAQ:ENTG). 1.99M were accumulated by Daruma Capital Management Ltd Liability Company. Keybank Natl Association Oh invested 0.01% of its portfolio in Entegris, Inc. (NASDAQ:ENTG). Citigroup Inc, a New York-based fund reported 13,337 shares. Panagora Asset Mngmt reported 488,433 shares. 7,166 were reported by Pacad Inv Ltd. Bnp Paribas Asset Mngmt Holdings invested in 0.1% or 405,507 shares. Scout Invests invested in 0.08% or 104,525 shares.

Analysts await Entegris, Inc. (NASDAQ:ENTG) to report earnings on February, 1. They expect $0.37 EPS, up 54.17% or $0.13 from last year’s $0.24 per share. ENTG’s profit will be $52.32 million for 22.11 P/E if the $0.37 EPS becomes a reality. After $0.40 actual EPS reported by Entegris, Inc. for the previous quarter, Wall Street now forecasts -7.50% negative EPS growth.

Among 12 analysts covering Entegris (NASDAQ:ENTG), 10 have Buy rating, 0 Sell and 2 Hold. Therefore 83% are positive. Entegris had 20 analyst reports since August 3, 2015 according to SRatingsIntel. Stifel Nicolaus maintained Entegris, Inc. (NASDAQ:ENTG) on Thursday, July 13 with “Buy” rating. The company was upgraded on Monday, January 25 by Pacific Crest. The stock of Entegris, Inc. (NASDAQ:ENTG) has “Buy” rating given on Friday, February 3 by Dougherty & Company. KeyBanc Capital Markets maintained it with “Buy” rating and $35.0 target in Thursday, October 26 report. The rating was upgraded by Dougherty & Company on Thursday, October 27 to “Buy”. On Monday, March 13 the stock rating was upgraded by Needham to “Buy”. The rating was maintained by Needham with “Buy” on Monday, September 18. On Friday, October 27 the stock rating was maintained by Citigroup with “Neutral”. The company was maintained on Thursday, October 19 by Needham. On Thursday, October 26 the stock rating was maintained by Needham with “Buy”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: